Recent Finacing
Recent Raise
Spun out of David Liu's lab, the company develops small-molecule therapeutics that engage exosites on target proteins to modulate function and advance programs toward clinical testing.
This company doesn't have industry or investor information available.
Total Raised
Funding rounds